The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.51
Bid: 1.51
Ask: 1.514
Change: -0.002 (-0.13%)
Spread: 0.004 (0.265%)
Open: 1.48
High: 1.528
Low: 1.48
Prev. Close: 1.512
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB FY 2021 Separate Financial results

22 Feb 2022 07:00

RNS Number : 3516C
Commercial Intnl Bank (Egypt) SAE
22 February 2022
 

Click on, or paste the following link into your web browser, to view the associated PDF document

 

http://www.rns-pdf.londonstockexchange.com/rns/3516C_1-2022-2-21.pdf

 

 

.Commercial International Bank (Egypt) S.A.E

 

Separate Financial Statements

 

December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate Balance Sheet as at December 31, 2021

 

 

Notes

Dec. 31, 2021

 

Dec. 31, 2020

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

Assets

 

 

 

 

 

Cash and balances at the central bank

15

43,385,222

 

33,572,597

 

Due from banks

16

79,991,287

 

86,997,034

 

Loans and advances to banks, net

18

312,216

 

776,980

 

Loans and advances to customers, net

19

144,765,808

 

118,854,880

 

Derivative financial instruments

20

225,376

 

248,759

 

Investments

 

 

 

 

 

- Financial Assets at Fair Value through P&L

21

240,987

 

359,959

 

- Financial Assets at Fair Value through OCI

21

192,390,931

 

147,646,432

 

- Financial assets at Amortized cost

21

20,318,767

 

25,020,917

 

- Investments in associates and subsidiaries

22

1,014,350

 

874,348

 

Other assets

23

11,141,917

 

9,095,212

 

Deferred tax assets (Liabilities)

32

460,026

 

437,772

 

Property and equipment

24

2,404,237

 

2,259,940

 

Total assets

 

496,651,124

 

426,144,830

 

Liabilities and equity

 

 

 

 

 

Liabilities

 

 

 

 

 

Due to banks

25

862,759

 

8,815,561

 

Due to customers

26

406,100,916

 

340,086,524

 

Derivative financial instruments

20

265,265

 

331,073

 

Current tax liabilities

 

2,234,985

 

859,582

 

Other liabilities

29

8,021,310

 

5,679,266

 

Issued debt instruments

27

1,557,263

 

-

 

Other loans

28

5,140,782

 

7,746,946

 

Other provisions

30

3,539,676

 

3,221,252

 

Total liabilities

 

427,722,956

 

366,740,204

 

Equity

 

 

 

 

 

Issued and paid up capital

31

19,702,418

 

14,776,813

 

Reserves

34

33,767,423

 

33,085,554

 

Reserve for employee stock ownership plan (ESOP)

34

1,674,392

 

1,064,648

 

Retained earnings *

34

13,783,935

 

10,477,611

 

Total equity and net profit for the year

 

68,928,168

 

59,404,626

 

Total liabilities and equity

 

496,651,124

 

426,144,830

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

(Audit report attached)

 

 

 

 

*

Including net profit for the current year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

Sherif Samy

 

CEO & Managing Director

Chairman

             

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

           

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate Income Statement for the year ended December 31, 2021

 

 

 

 

 

 

 

 

 

Notes

 

 

Dec. 31, 2021

 

 

 

 

Dec. 31, 2020

 

 

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

Interest and similar income

 

 

44,945,445

 

 

42,070,598

 

Interest and similar expense

 

 

(20,057,935)

 

 

(16,980,635)

 

Net interest income

6

 

 

24,887,510

 

 

25,089,963

 

 

 

 

 

 

 

 

 

Fee and commission income

 

 

4,036,955

 

 

3,053,536

 

Fee and commission expense

 

 

(1,654,671)

 

 

(983,450)

 

 

Net fee and commission income

7

 

2,382,284

 

 

2,070,086

 

 

 

 

 

 

 

 

 

Dividend income

8

 

84,700

 

 

98,175

 

Net trading income

9

 

696,738

 

 

395,701

 

Profits (Losses) on financial investments

21

 

684,417

 

 

922,832

 

Administrative expenses

10

 

(6,096,221)

 

 

(5,552,800)

 

Other operating (expenses) income

11

 

(1,981,093)

 

 

(2,737,550)

 

Impairment release (charges) for credit losses

12

 

(1,677,450)

 

 

(4,989,288)

 

Profit before income tax

 

 

18,980,885

 

 

15,297,119

 

 

 

 

 

 

 

 

 

Income tax expense

13

 

(5,678,659)

 

 

(5,084,670)

 

Deferred tax assets (Liabilities)

 

 

118,159

 

 

87,433

 

Net profit for the year

 

 

13,420,385

 

 

10,299,882

 

 

 

 

 

 

 

 

 

Earnings per share

14

 

 

 

 

 

 

Basic

 

 

6.10

 

 

4.67

 

Diluted

 

 

6.06

 

 

4.63

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

 

 

 

 

Sherif Samy

 

 

CEO & Managing Director

 

 

 

 

Chairman

 

         

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate Statement of Other Comprehensive Income for the year ended December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

Dec. 31, 2021

 

 

 

 

Dec. 31, 2020

 

 

 

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

 

 

Net profit for the year

 

 

13,420,385

 

 

10,299,882

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income items that will not be reclassified to the Profit or Loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of equity instruments measured at fair value through other comprehensive income after tax impact related to OCI that will not be reclassified to the profit or loss

 

 

(149,323)

 

 

(13,966)

 

 

Other comprehensive income items that is or may be reclassified to the profit or loss:

 

 

 

 

 

 

 

 

Change in fair value of debt instruments measured at fair value through other comprehensive income after tax impact related to OCI that will be reclassified to the profit or loss

 

 

(2,208,603)

 

 

763,176

 

 

Change in fair value from selling FVOCI financial instruments

 

 

(702,776)

 

 

(1,018,469)

 

 

Transferred from reserve on disposal of financial assets at fair value through OCI

 

 

(177,488)

 

 

(76,717)

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

 

 

(93,566)

 

 

205,182

 

 

Total other comprehensive income for the year

 

 

10,088,629

 

 

10,159,088

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate Cash Flow for the Year Ended December 31, 2021

 

 

 

 

 

 

Notes

Dec. 31, 2021

 

Dec. 31, 2020

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

Profit before income tax

 

18,980,885

 

15,297,119

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

 

 

Fixed assets depreciation

24

858,609

 

677,501

Impairment charge for credit losses (Loans and advances to customers and banks)

12

1,753,908

 

4,777,592

Other provisions charges

30

381,601

 

1,232,731

Impairment charge for credit losses (due from banks)

12

17,108

 

6,514

Impairment (Released) charge for credit losses (financial investments)

12

(93,566)

 

205,182

Impairment (Released) charge for other assets

 

31,975

 

69,217

Exchange revaluation differences for financial assets at fair value through OCI and at amortized cost

21

17,261

 

249,642

Impairment (Released) charge financial assets at fair value through OCI

21

-

 

79,126

Utilization of other provisions

30

(45,483)

 

(2,382)

Other provisions no longer used

30

(2,451)

 

(13,273)

Exchange differences of other provisions

30

(15,243)

 

(7,193)

Losses (profits) from selling property and equipment

11

(2,947)

 

(1,094)

Losses (profits) from selling financial investments

21

(702,776)

 

(1,018,469)

Shares based payments

 

609,744

 

552,438

Impairment (Released) charges of investments in associates and subsidiaries

21

18,359

 

16,511

Operating losses (profits) before changes in operating assets and liabilities

 

21,806,984

 

22,121,162

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net decrease (increase) in assets and liabilities

 

 

 

 

Due from banks

15 - 16

(17,927,084)

 

(10,899,927)

Financial assets at fair value through P&L

21

118,972

 

58,822

Derivative financial instruments

20

(42,425)

 

16,109

Loans and advances to banks and customers

18 - 19

(27,183,640)

 

(4,276,558)

Other assets

41

(2,155,845)

 

649,301

Due to banks

25

(7,952,802)

 

(2,995,046)

Due to customers

26

66,014,392

 

35,602,869

Income tax obligations paid

29

(3,443,674)

 

(3,779,782)

Other liabilities

 

1,490,795

 

(7,700,878)

Net cash generated from operating activities

 

30,725,673

 

28,796,072

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

Proceeds from investments in associates.

 

-

 

750

Payments for investment in subsidiaries and associates.

 

(158,360)

 

(721,352)

Payment for purchases of property, equipment and branches constructions

 

(942,173)

 

(987,061)

Proceeds from selling property and equipment

11

2,947

 

1,094

Proceeds from redemption of financial assets at amortized cost

21

4,705,849

 

82,203,469

Payment for purchases of financial assets at amortized cost

21

(3,844)

 

-

Payment for purchases of financial assets at fair value through OCI

21

(250,190,493)

 

(112,382,696)

Proceeds from selling financial assets at fair value through OCI

 

203,196,606

 

54,970,226

Net cash used in (generated from) investing activities

 

(43,389,468)

 

23,084,430

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate Cash Flow for the Year Ended December 31, 2021 (Cont.)

 

 

 

 

 

 

 

Dec. 31, 2021

 

Dec. 31, 2020

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

Decreased (increase) in long term loans

28

(2,606,164)

 

4,474,200

Dividend paid

 

(1,360,652)

 

(3,370,464)

Issued debt instruments

 

1,557,263

 

-

Capital increase

 

-

 

85,992

Net cash used in (generated from) financing activities

 

(2,409,553)

 

1,189,728

 

 

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalent during the year

 

(15,073,348)

 

53,070,230

Beginning balance of cash and cash equivalent

 

75,965,247

 

22,895,017

Cash and cash equivalent at the end of the year

 

60,891,899

 

75,965,247

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

Cash and balances at the central bank

15

43,385,222

 

33,572,597

Due from banks

16

80,031,726

 

87,020,365

Treasury bills and other governmental notes

17

41,579,504

 

39,464,714

Obligatory reserve balance with CBE

15

(38,016,793)

 

(27,610,380)

Due from banks with maturities more than three months

 

(23,801,430)

 

(16,280,760)

Treasury bills with maturity more than three months

 

(42,286,330)

 

(40,201,289)

Total cash and cash equivalent

 

60,891,899

 

75,965,247

'

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate Statement of Changes in Shareholders' Equity for the Year Ended December 31, 2020

 

 

 

 

Dec. 31, 2020

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

 

 

 

 

 

Beginning balance

14,690,821

2,188,029

16,474,429

1,549,445

 13,466

4,111,781

5,164

11,803,555

963,152

51,799,842

 

 

 

 

 

Capital increase

85,992

-

-

-

-

-

-

-

-

85,992

 

 

 

 

 

Transferred to reserves

-

590,106

8,291,229

-

1,440

-

-

(8,431,833)

(450,942)

-

 

 

 

 

 

Dividend paid

-

-

-

-

-

-

-

(3,370,464)

-

(3,370,464)

 

 

 

 

 

Net profit for the year

-

-

-

-

-

-

-

10,299,882

-

10,299,882

 

 

 

 

 

Transferred from reserve on disposal of financial assets at fair value through OCI

-

-

-

-

-

(76,717)

-

76,717

-

-

 

 

 

 

 

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

101,013

-

101,013

 

 

 

 

 

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(269,259)

-

-

-

(269,259)

 

 

 

 

 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

1,259

(1,259)

-

-

 

 

 

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

205,182

-

-

-

205,182

 

 

 

 

 

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

 

-

-

-

552,438

552,438

 

 

 

 

 

Ending balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate Statement of Changes in Shareholders' Equity for the Year Ended December 31, 2021

 

 

 

 

 

 

 

 

 

Dec. 31, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

 

 

 

 

 

Beginning balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626

 

 

 

 

 

Capital increase

4,925,605

-

(4,925,605)

-

-

-

-

-

-

-

 

 

 

 

 

Transferred to reserves

-

514,939

8,420,479

-

1,094

-

-

(8,936,512)

-

-

 

 

 

 

 

Dividend paid

-

-

-

-

-

-

-

(1,360,652)

-

(1,360,652)

 

 

 

 

 

Net profit for the year

-

-

-

-

-

-

-

13,420,385

-

13,420,385

 

 

 

 

 

Transferred from reserve on disposal of financial assets at fair value through OCI

-

-

-

-

-

(177,488)

-

177,488

-

-

 

 

 

 

 

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

8,333

-

8,333

 

 

 

 

 

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(3,060,702)

-

-

-

(3,060,702)

 

 

 

 

 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,718

(2,718)

-

-

 

 

 

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

 

-

(93,566)

-

-

-

(93,566)

 

 

 

 

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

609,744

609,744

 

 

 

 

 

Ending balance

19,702,418

3,293,074

28,260,532

1,549,445

16,000

639,231

9,141

13,783,935

1,674,392

68,928,168

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR PPUWWPUPPPPG
Date   Source Headline
13th Nov 20087:00 amRNSInterim Management Statement
13th Nov 20087:00 amRNS3rd Quarter Results
5th Nov 20083:40 pmRNSPrice Monitoring Extension
31st Oct 20083:41 pmRNSPrice Monitoring Extension
24th Oct 20083:41 pmRNSPrice Monitoring Extension
20th Oct 20083:40 pmRNSPrice Monitoring Extension
10th Oct 20083:40 pmRNSPrice Monitoring Extension
9th Oct 20083:47 pmRNSSecond Price Monitoring Extn
9th Oct 20083:41 pmRNSPrice Monitoring Extension
2nd Oct 20083:46 pmRNSSecond Price Monitoring Extn
2nd Oct 20083:40 pmRNSPrice Monitoring Extension
1st Oct 20083:45 pmRNSSecond Price Monitoring Extn
1st Oct 20083:40 pmRNSPrice Monitoring Extension
30th Sep 20083:47 pmRNSSecond Price Monitoring Extn
30th Sep 20083:41 pmRNSPrice Monitoring Extension
17th Sep 200811:57 amRNSResponse to Market Rumour
8th Sep 20088:54 amRNSDirectorate Change
29th Aug 20083:40 pmRNSPrice Monitoring Extension
18th Aug 20083:45 pmRNSSecond Price Monitoring Extn
18th Aug 20083:40 pmRNSPrice Monitoring Extension
13th Aug 20087:00 amRNSDirectorate Change
13th Aug 20087:00 amRNSInterim Management Statement
13th Aug 20087:00 amRNSInterim Results
8th Aug 20083:40 pmRNSPrice Monitoring Extension
7th Aug 20083:40 pmRNSPrice Monitoring Extension
4th Aug 20088:50 amRNSHolding(s) in Company
16th Jul 20087:10 amRNSRe: Stock Dividend
30th Jun 20087:00 amRNSpress release
14th May 20087:36 amRNSAAIB Merger
12th May 20083:48 pmRNS1st Quarter Results
6th May 20083:45 pmRNSSecond Price Monitoring Extn
6th May 20083:40 pmRNSPrice Monitoring Extension
30th Apr 20082:01 pmRNSChanges in IR Team
18th Mar 20082:55 pmRNSAGM Statement
17th Mar 20087:00 amRNSFormal Notice
25th Feb 20087:00 amRNSFurther re Final Results
25th Feb 20087:00 amRNSFinal Results
25th Feb 20087:00 amRNSProposed Stock Dividend
12th Nov 20077:04 amRNS3rd Quarter Results
1st Oct 20077:02 amRNSStatement re Possible Offer
8th Aug 20077:00 amRNSInterim Results
31st May 20073:44 pmRNSPrice Monitoring Extension
14th May 20077:00 amRNS1st Quarter Results
15th Mar 200712:41 pmRNSDividend Declaration
6th Feb 20074:13 pmRNSFinal Results - Replacement
6th Feb 20078:56 amRNSFinal Results
15th Jan 20078:00 amRNSStatement re. Press Comment
6th Nov 20067:00 amRNS3rd Quarter Results
30th Oct 20069:44 amRNSStrategic Alliance
17th Oct 20061:08 pmRNSFormal Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.